/SPAGO.ST
SPAGO.ST Stock - Spago Nanomedical AB (publ)
Healthcare|BiotechnologySTO
$0.10+0.49%
+$0.00 (+0.49%) • Dec 23
48
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.68
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.11
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SPAGO.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.10 – $0.10
TARGET (TP)$0.12
STOP LOSS$0.09
RISK/REWARD1:1.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.30
52W High$0.46
52W Low$0.08
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.91M | $1.20M | $1.05M | $660,000 | $342,000 |
| Gross Profit | $-12,358,000 | $-23,283,000 | $-15,604,000 | $-16,776,000 | $-416,000 |
| Gross Margin | -646.7% | -1935.4% | -1480.5% | -2541.8% | -121.6% |
| Operating Income | $-33,713,000 | $-47,233,000 | $-39,465,000 | $-39,192,000 | $-18,962,000 |
| Net Income | $-32,509,000 | $-42,223,000 | $-39,309,000 | $-39,075,000 | $-18,903,000 |
| Net Margin | -1701.2% | -3509.8% | -3729.5% | -5920.5% | -5527.2% |
| EPS | $-0.11 | $-0.21 | $-0.29 | $-0.46 | $-0.32 |
Company Overview
Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SPAGO.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q4 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 29, 2025 | — | $-0.01 | — | — |
Q2 2025 | May 7, 2025 | — | $-0.02 | — | — |
Q1 2025 | Feb 6, 2025 | — | $-0.02 | — | — |
Q4 2024 | Nov 6, 2024 | — | $-0.03 | — | — |
Q3 2024 | Aug 21, 2024 | — | $-0.03 | — | — |
Q2 2024 | May 2, 2024 | — | $-0.03 | — | — |
Q1 2024 | Feb 7, 2024 | — | $-0.04 | — | — |
Q4 2023 | Nov 3, 2023 | — | $-0.04 | — | — |
Q3 2023 | Jul 31, 2023 | — | $-0.04 | — | — |
Q2 2023 | May 9, 2023 | — | $-0.07 | — | — |
Q1 2023 | Feb 2, 2023 | — | $-0.06 | — | — |
Q4 2022 | Nov 8, 2022 | — | $-0.05 | — | — |
Q3 2022 | Aug 24, 2022 | — | $-0.11 | — | — |
Q2 2022 | Apr 27, 2022 | — | $-0.12 | — | — |
Q1 2022 | Feb 2, 2022 | — | $-0.14 | — | — |
Q4 2021 | Nov 10, 2021 | — | $-0.12 | — | — |
Q3 2021 | Aug 24, 2021 | — | $-0.14 | — | — |
Q2 2021 | Apr 28, 2021 | — | $-0.09 | — | — |
Q2 2021 | Apr 13, 2021 | — | $-0.07 | — | — |
Q4 2020 | Nov 10, 2020 | — | $-0.07 | — | — |
Latest News
Loading news...
Frequently Asked Questions about SPAGO.ST
What is SPAGO.ST's current stock price?
Spago Nanomedical AB (publ) (SPAGO.ST) is currently trading at $0.10 per share. The stock has moved +0.49% today.
What is the analyst price target for SPAGO.ST?
No analyst price targets are currently available for this stock.
What sector is Spago Nanomedical AB (publ) in?
Spago Nanomedical AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is SPAGO.ST's market cap?
Spago Nanomedical AB (publ) has a market capitalization of $0.04 billion, making it a small-cap company.
Does SPAGO.ST pay dividends?
No, Spago Nanomedical AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACOU.ST
AcouSort AB (publ)
$2.64
Mkt Cap: $0.1B
ACTI.ST
Active Biotech AB (publ)
$0.04
Mkt Cap: $0.1B
ATORX.ST
Alligator Bioscience AB (publ)
$0.34
Mkt Cap: $0.0B
HEART.ST
Scandinavian Real Heart AB (Publ)
$14.00
Mkt Cap: $0.1B
LPGO.ST
Lipigon Pharmaceuticals AB (publ)
$0.01
Mkt Cap: $0.0B
ONCOZ.ST
OncoZenge AB (publ)
$6.55
Mkt Cap: $0.1B
PILA.ST
Pila Pharma AB (publ)
$2.20
Mkt Cap: $0.1B
SIMRIS-B.ST
Simris Alg AB (publ)
$0.05
Mkt Cap: $0.0B
SPEC.ST
SpectraCure AB (publ)
$0.16
Mkt Cap: $0.1B
SPRINT.ST
Sprint Bioscience AB (publ)
$1.45
Mkt Cap: $0.2B
Explore stocks similar to SPAGO.ST for comparison